Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Olink Bioscience's Proseek Multiplex CVD I 96x96

Premium

Olink Bioscience this week launched Proseek Multiplex CVD I 96x96, a new protein biomarker panel for cardiovascular disease.

According to Olink, its new multiplex immunoassay allows the analysis of 92 cardiovascular-related protein biomarkers across 96 samples simultaneously. The assay requires one microliter of sample is required. The panel contains known cardiovascular and inflammatory markers as well as a few exploratory proteins that serve as new cardiovascular markers.

Olink said that the new panel can be run on Fluidigm's BioMark HD System. Using the BioMark HD System with the Proseek Multiplex CVD I 96x96, a researcher can now obtain results for up to 9,216 reactions in just a few hours, the firm said.

BioArray News discussed the new panel and other company developments with its CEO Simon Fredriksson during a recent visit to the firm's base in Uppsala, Sweden (BAN 10/15/2013).

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.